Tretinoin vs adapalene — which retinoid is right for you.

Tretinoin and adapalene are both retinoids — topical vitamin A derivatives that bind to retinoic acid receptors in skin cells and produce similar clinical outcomes over time. Both have extensive bodies of published research. Both improve acne, textural irregularity, and photoageing with consistent use. They are not the same compound, and the differences between them are clinically relevant when deciding where to start.

The mechanism: how similar, how different

Both tretinoin and adapalene bind to nuclear retinoic acid receptors (RARs) and regulate gene expression in keratinocytes. The result, in both cases, is accelerated cell turnover, reduced follicular plugging, and — over months of consistent use — stimulated collagen synthesis.

The difference is in receptor selectivity. Tretinoin (all-trans retinoic acid) binds non-selectively to all three RAR subtypes (α, β, γ). Adapalene binds selectively to RAR-β and RAR-γ only, and has lower affinity for the receptors that trigger the inflammatory cascade tretinoin can initiate. This selectivity is the primary reason adapalene is better tolerated: it produces the same therapeutic outcomes through retinoid receptor activation with a lower rate of retinoid dermatitis (the redness, dryness, and peeling that characterise the adaptation phase).

Adapalene also has greater chemical stability than tretinoin — it is not degraded by UV exposure or oxidation, which means morning application is an option, and there is less formulation complexity around stability.

Potency: what the evidence says

Tretinoin at 0.025%–0.1% is more potent than adapalene at 0.1%–0.3% in head-to-head comparisons on acne lesion reduction and photoageing markers — but the absolute difference in efficacy at standard concentrations is smaller than the difference in side-effect profiles. Studies comparing adapalene 0.1% to tretinoin 0.025% (the lowest standard concentration) show similar efficacy with significantly better adapalene tolerability. Tretinoin at 0.05% and 0.1% produces faster results in photoageing outcomes; adapalene has not been as extensively studied for this indication.

For acne — the indication with the deepest evidence base for both — adapalene 0.1% and tretinoin 0.025%–0.05% produce comparable lesion reductions in randomised controlled trials, with adapalene consistently showing fewer adverse events. For photoageing and fine lines, tretinoin has the longer-established evidence, though adapalene's collagen-stimulating effect through RAR-β/γ binding is documented.

Access and cost

In Australia, adapalene is available without a prescription as Differin gel 0.1% (approximately AUD 20–30 over the counter). This is a meaningful access difference — adapalene 0.1% in a patient without a Medicare prescription costs the same as a pharmacy transaction; tretinoin requires a GP or dermatologist appointment, a script, and pharmacy cost without PBS subsidy (typically AUD 30–80 depending on compounding vs branded formulation and concentration).

For someone without existing retinoid experience, adapalene OTC is the lower-friction entry point. For someone with a GP relationship and a specific indication (significant photoageing, moderate-to-severe acne, hyperpigmentation that has not responded to OTC options), tretinoin via prescription is justified by the additional potency.

Side-effect profile

Both retinoids produce an adaptation phase: dryness, flaking, tightness, and temporary increases in sensitivity. Adapalene consistently produces a milder adaptation phase in both head-to-head and observational studies. The purging phenomenon — a temporary increase in breakouts during the first four to six weeks as accelerated cell turnover clears pre-formed comedonal material to the surface — occurs with both.

Tretinoin has an additional photosensitising effect that is more pronounced than adapalene's. Applied in the evening on clean, dry skin and covered by SPF the following morning, this is manageable — but it is a reason tretinoin is typically prescribed for evening-only use, whereas adapalene can be applied morning or evening.

Neither retinoid should be used during pregnancy. Both are classified as Pregnancy Category D in Australia — animal studies have shown evidence of foetal harm, and while the risk from topical application is lower than systemic retinoids, the recommendation is to avoid both until after pregnancy and breastfeeding.

Introduction protocol: the same for both

The correct introduction approach is identical for tretinoin and adapalene: start at the lowest concentration, apply two evenings per week for the first four to six weeks, use a barrier-supporting moisturiser, apply SPF every morning without exception. Increase frequency only when the skin is tolerating the current schedule without sustained redness or barrier disruption.

The most common mistake with both — abandoning the retinoid during the purging or adaptation phase — is the same. The most common error in introduction — applying more than a pea-sized amount, or applying to damp skin immediately after washing — is the same. A thoughtful, slow introduction is the correct approach regardless of which compound you choose.

Which to choose

Start with adapalene if: you have no current retinoid experience; you have sensitive or reactive skin; you prefer OTC access; your primary concern is acne or prevention; you want to build tolerance before considering a prescription option.

Consider tretinoin if: you have used adapalene consistently for three to six months and want to progress to a more potent option; your primary concern is photoageing or significant hyperpigmentation; you have a GP or dermatologist relationship and a clear indication; you are comfortable with a slightly more demanding introduction period.

The correct answer for most people new to retinoids is adapalene first. It is well-tolerated, evidence-supported, accessible, and builds the retinoid tolerance that makes a subsequent transition to tretinoin — if that becomes the goal — significantly easier. Many people find adapalene at 0.1% used consistently is all they need or want. That is not a compromise. It is a well-supported decision.